Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Greater Cannabis Company (GCAN) Common Equity (2016 - 2026)

Greater Cannabis Company has reported Common Equity over the past 7 years, most recently at -$544830.0 for Q4 2022.

  • For Q4 2022, Common Equity fell 16.15% year-over-year to -$544830.0; the TTM value through Dec 2022 reached -$544830.0, down 16.15%, while the annual FY2022 figure was -$544830.0, 16.15% down from the prior year.
  • Common Equity for Q4 2022 was -$544830.0 at Greater Cannabis Company, up from -$561429.0 in the prior quarter.
  • Over five years, Common Equity peaked at $100779.0 in Q2 2018 and troughed at -$2.4 million in Q1 2020.
  • A 5-year average of -$610314.4 and a median of -$553129.5 in 2022 define the central range for Common Equity.
  • Biggest five-year swings in Common Equity: crashed 729.12% in 2019 and later skyrocketed 91.68% in 2021.
  • Year by year, Common Equity stood at -$563786.0 in 2018, then crashed by 174.33% to -$1.5 million in 2019, then surged by 81.91% to -$279788.0 in 2020, then plummeted by 67.65% to -$469062.0 in 2021, then decreased by 16.15% to -$544830.0 in 2022.
  • Business Quant data shows Common Equity for GCAN at -$544830.0 in Q4 2022, -$561429.0 in Q3 2022, and -$641653.0 in Q2 2022.